These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19010907)

  • 1. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Shi Q; Daikoku T; Dey SK; DuBois RN
    Cancer Res; 2008 Nov; 68(22):9331-7. PubMed ID: 19010907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
    Mann JR; Backlund MG; Buchanan FG; Daikoku T; Holla VR; Rosenberg DW; Dey SK; DuBois RN
    Cancer Res; 2006 Jul; 66(13):6649-56. PubMed ID: 16818638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin dehydrogenase is a target for successful induction of cervical ripening.
    Kishore AH; Liang H; Kanchwala M; Xing C; Ganesh T; Akgul Y; Posner B; Ready JM; Markowitz SD; Word RA
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6427-E6436. PubMed ID: 28716915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
    Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
    Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
    J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
    von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
    Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells.
    Zuo X; Morris JS; Broaddus R; Shureiqi I
    Oncogene; 2009 Mar; 28(12):1496-505. PubMed ID: 19198625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex.
    Peinado H; Ballestar E; Esteller M; Cano A
    Mol Cell Biol; 2004 Jan; 24(1):306-19. PubMed ID: 14673164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
    Myung SJ; Rerko RM; Yan M; Platzer P; Guda K; Dotson A; Lawrence E; Dannenberg AJ; Lovgren AK; Luo G; Pretlow TP; Newman RA; Willis J; Dawson D; Markowitz SD
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12098-102. PubMed ID: 16880406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
    Ray A; Alalem M; Ray BK
    J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.
    Tong M; Ding Y; Tai HH
    Biochem Pharmacol; 2006 Sep; 72(6):701-9. PubMed ID: 16844092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
    Colussi C; Mozzetta C; Gurtner A; Illi B; Rosati J; Straino S; Ragone G; Pescatori M; Zaccagnini G; Antonini A; Minetti G; Martelli F; Piaggio G; Gallinari P; Steinkuhler C; Clementi E; Dell'Aversana C; Altucci L; Mai A; Capogrossi MC; Puri PL; Gaetano C
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19183-7. PubMed ID: 19047631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy.
    Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ
    Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
    Yang L; Amann JM; Kikuchi T; Porta R; Guix M; Gonzalez A; Park KH; Billheimer D; Arteaga CL; Tai HH; DuBois R; Carbone DP; Johnson DH
    Cancer Res; 2007 Jun; 67(12):5587-93. PubMed ID: 17575121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.